HCA Healthcare, Inc.
HCA
$376.59
-$0.05-0.01%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 71.59B | 70.60B | 69.62B | 68.35B | 66.72B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.59B | 70.60B | 69.62B | 68.35B | 66.72B |
| Cost of Revenue | 42.31B | 41.93B | 41.37B | 40.82B | 40.26B |
| Gross Profit | 29.28B | 28.68B | 28.25B | 27.52B | 26.46B |
| SG&A Expenses | 1.05B | 1.05B | 994.00M | 994.00M | 994.00M |
| Depreciation & Amortization | 3.38B | 3.31B | 3.25B | 3.17B | 3.12B |
| Other Operating Expenses | 14.01B | 13.77B | 13.51B | 13.17B | 12.59B |
| Total Operating Expenses | 60.74B | 60.06B | 59.12B | 58.16B | 56.96B |
| Operating Income | 10.84B | 10.55B | 10.50B | 10.18B | 9.75B |
| Income Before Tax | 8.60B | 8.52B | 8.74B | 8.46B | 8.03B |
| Income Tax Expenses | 1.92B | 1.87B | 1.90B | 1.83B | 1.68B |
| Earnings from Continuing Operations | 6.68K | 6.66K | 6.83K | 6.63K | 6.35K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -901.00M | -897.00M | -903.00M | -887.00M | -880.00M |
| Net Income | 5.78B | 5.76B | 5.93B | 5.74B | 5.47B |
| EBIT | 10.84B | 10.55B | 10.50B | 10.18B | 9.75B |
| EBITDA | 14.22B | 13.86B | 13.75B | 13.36B | 12.87B |
| EPS Basic | 22.69 | 22.19 | 22.48 | 21.52 | 20.27 |
| Normalized Basic EPS | 18.03 | 17.05 | 16.77 | 15.98 | 14.84 |
| EPS Diluted | 22.49 | 21.97 | 22.27 | 21.30 | 20.06 |
| Normalized Diluted EPS | 17.88 | 16.90 | 16.62 | 15.83 | 14.69 |
| Average Basic Shares Outstanding | 1.02B | 1.04B | 1.05B | 1.07B | 1.08B |
| Average Diluted Shares Outstanding | 1.03B | 1.05B | 1.06B | 1.08B | 1.09B |
| Dividend Per Share | 2.70 | 2.64 | 2.58 | 2.52 | 2.46 |
| Payout Ratio | 11.85% | 11.98% | 11.55% | 11.82% | 12.27% |